Prescription drug · ANDA
Colestipol Hydrochloride NDC 0115-5213
Colestipol hydrochloride 5 g/1 · Suspension · Oral · Amneal Pharmaceuticals of New York LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0115-5213-02 | 0011552130200115521302 | 100 SUSPENSION in 1 BOTTLE (0115-5213-02)Marketed from May 2, 2006 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Colestipol Hydrochloride
- Generic name (nonproprietary)
- colestipol hydrochloride
- Active ingredients
- Colestipol hydrochloride — 5 g/1
- Dosage form
- Suspension
- Route
- Oral
- Labeler
- Amneal Pharmaceuticals of New York LLCNDC labeler code 0115
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 077277
- Marketing start
- Listing expires
- Other FDA classes
- Bile-acid Binding Activity (Mechanism)
- Identifiers
- Product ID 0115-5213_78f0e0f5-e61e-4c11-8e35-b65bcdfcfc06SPL ID 78f0e0f5-e61e-4c11-8e35-b65bcdfcfc06SPL set ID 839354bd-cbac-4d18-8c02-b1b93766af38RxCUI 1048450UNII X7D10K905G
- Pharmacologic class
- Bile Acid Sequestrant
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400115521302followed by a unit qualifier and the quantityPackage 00115-5213-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Since no drug is innocuous, strict attention should be paid to the indications and contraindications, particularly when selecting drugs for chronic long-term use. Colestipol hydrochloride for oral suspension is indicated as adjunctive therapy to diet for the reduction of elevated serum total and low-density lipoprotein (LDL) cholesterol in patients with primary hypercholesterolemia (elevated low density lipoproteins [LDL] cholesterol) who do not respond adequately to diet. Generally, colestipol hydrochloride for oral suspension has no clinically significant effect on serum triglycerides, but with its use triglyceride levels may be raised in some patients. Therapy with l…
Excerpt only. Read the full label for complete information.
About NDC 0115-5213
- What is NDC 0115-5213?
- 0115-5213 is the product NDC for Colestipol Hydrochloride, Colestipol hydrochloride 5 g/1 suspension, listed with the FDA by Amneal Pharmaceuticals of New York LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Colestipol Hydrochloride.
- What is the active ingredient?
- Colestipol hydrochloride.
- Who is the labeler?
- Amneal Pharmaceuticals of New York LLC, NDC labeler code 0115. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Colestipol Hydrochloride?
- 11 other product NDCs are listed under this name. See all Colestipol Hydrochloride NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Colestipol Hydrochloride products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Colestipol Hydrochloride | Colestipol hydrochloride 1 g/1 | Tablet, Film coatedOral | NorthStar Rx LLC | 72603-817 | 72603-0817-01 |
| Colestipol Hydrochloride | Colestipol hydrochloride 1 g/1 | Tablet, Film coatedOral | Ingenus Pharmaceuticals, LLC | 50742-284 | 50742-0284-12 |
| Colestipol Hydrochloride | Colestipol hydrochloride 1 g/1 | TabletOral | Edenbridge Pharmaceuticals LLC. | 42799-115 | 42799-0115-01 |
| Colestipol Hydrochloride | Colestipol hydrochloride 1 g/1 | Tablet, Film coatedOral | ANI Pharmaceuticals, Inc. | 62559-395 | 62559-0395-12 |
| Colestipol Hydrochloride | Colestipol hydrochloride 1 g/1 | Tablet, Film coatedOral | American Health Packaging | 60687-715 | 60687-0715-21 |
| Colestipol hydrochloride | Colestipol hydrochloride 1 g/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc. | 70710-1467 | 70710-1467-0570710-1467-07 |
| Colestipol hydrochloride | Colestipol hydrochloride 1 g/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | 70771-1653 | 70771-1653-0570771-1653-07 |
| Colestipol Hydrochloride | Colestipol hydrochloride 1 g/1 | Tablet, Film coatedOral | Amneal Pharmaceuticals of New York LLC | 0115-5211 | 00115-5211-0200115-5211-16 |
| Colestipol Hydrochloride | Colestipol hydrochloride 5 g/1 | SuspensionOral | Amneal Pharmaceuticals of New York LLC | 0115-5212 | 00115-5212-1800115-5212-29 |
| Colestipol Hydrochloride | Colestipol hydrochloride 1 g/1 | TabletOral | Mylan Pharmaceuticals Inc. | 59762-0450 | 59762-0450-01 |
Other NDCs under ANDA 077277
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Colestipol Hydrochloride | Colestipol hydrochloride 5 g/1 | SuspensionOral | Amneal Pharmaceuticals of New York LLC | 0115-5212 |